Pfizer and Irish rival Allergan agree record $160bn merger

US giant drugmaker Pfizer said it had agreed to merge with Irish rival Allergan in a deal worth US$160bn, making it the biggest deal in pharmaceuticals history.

The firms said the merger would create an industry leader that would have more than 100 treatments in mid to late stage development.